Search Results

There are 769 results for: content related to: Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures

  1. Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 7, July 2014, Pages: 667–678, Shahrul Mt-Isa, Christine E. Hallgreen, Nan Wang, Torbjörn Callréus, Georgy Genov, Ian Hirsch, Stephen F. Hobbiger, Kimberley S. Hockley, Davide Luciani, Lawrence D. Phillips, George Quartey, Sinan B. Sarac, Isabelle Stoeckert, Ioanna Tzoulaki, Alain Micaleff, Deborah Ashby and On behalf of the IMI-PROTECT benefit–risk participants

    Article first published online : 13 MAY 2014, DOI: 10.1002/pds.3636

  2. Safety profile of oseltamivir during the 2009 influenza pandemic

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 532–543, Barbara Donner, Silvia Bader-Weder, Roman Schwarz, Michael M. Peng, James Robert Smith and Viswanathan Niranjan

    Article first published online : 29 MAR 2011, DOI: 10.1002/pds.2136

  3. Safety aspects of antiepileptic drugs—focus on pharmacovigilance

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 11–20, Cecilie Johannessen Landmark and Svein I. Johannessen

    Article first published online : 8 NOV 2011, DOI: 10.1002/pds.2269

  4. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 2, February 2015, Pages: 176–186, Florian Meier, Renke Maas, Anja Sonst, Andrius Patapovas, Fabian Müller, Bettina Plank-Kiegele, Barbara Pfistermeister, Oliver Schöffski, Thomas Bürkle and Harald Dormann

    Article first published online : 17 JUN 2014, DOI: 10.1002/pds.3663

  5. Off-label use of second generation antipsychotics for post-traumatic stress disorder in the Department of Veterans Affairs: time trends and sociodemographic, comorbidity, and regional correlates

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 1, January 2014, Pages: 77–86, Mark S. Bauer, Austin Lee, Mingfei Li, Laura Bajor, Ann Rasmusson and Lewis E. Kazis

    Article first published online : 31 AUG 2013, DOI: 10.1002/pds.3507

  6. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Article first published online : 8 JUN 2012, DOI: 10.1002/pds.3296

  7. Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates?

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 718–728, Kueiyu Joshua Lin, Luis A. García Rodríguez and Sonia Hernández-Díaz

    Article first published online : 27 MAY 2011, DOI: 10.1002/pds.2153

  8. Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 494–506, Christopher G. Rowan, Steven M. Brunelli, Jeffrey Munson, James Flory, Peter P. Reese, Sean Hennessy, James Lewis, Daniel Mines, Jeffrey S. Barrett, Warren Bilker and Brian L. Strom

    Article first published online : 16 MAR 2012, DOI: 10.1002/pds.3199

  9. Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 11, November 2012, Pages: 1202–1215, Vincent Lo Re III, Kevin Haynes, Eileen E. Ming, Jennifer Wood Ives, Laura N. Horne, Kimberly Fortier, Dena M. Carbonari, Sean Hennessy, Serena Cardillo, Peter P. Reese, K. Rajender Reddy, David Margolis, Andrea Apter, Stephen E. Kimmel, Jason Roy, Cristin P. Freeman, Hanieh Razzaghi, Crystal N. Holick, Daina B. Esposito, Tjeerd-Pieter Van Staa, Harshvinder Bhullar and Brian L. Strom

    Article first published online : 4 JUL 2012, DOI: 10.1002/pds.3318

  10. You have full text access to this OnlineOpen article
    Methodological gaps in the assessment of risk minimization interventions: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 572–579, Inna Gridchyna, Anne-Marie Cloutier, Lenhangmbong Nkeng, Camille Craig, Sarah Frise and Yola Moride

    Article first published online : 24 FEB 2014, DOI: 10.1002/pds.3596

  11. Case-crossover study design in pharmacoepidemiology: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 11, November 2013, Pages: 1146–1153, Giulia P. Consiglio, Andrea M. Burden, Malcolm Maclure, Lisa McCarthy and Suzanne M. Cadarette

    Article first published online : 13 SEP 2013, DOI: 10.1002/pds.3508

  12. Ophthalmic adverse drug reactions to systemic drugs: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 3, March 2014, Pages: 221–233, Ana Miguel, Filipe Henriques, Luís Filipe Azevedo and Altamiro Costa Pereira

    Article first published online : 27 JAN 2014, DOI: 10.1002/pds.3566

  13. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 835–843, Hilda J. I. de Jong, Rob J. Vandebriel, Siti R. F. Saldi, Liset van Dijk, Henk van Loveren, Jan Willem Cohen Tervaert and Olaf H. Klungel

    Article first published online : 6 JUN 2012, DOI: 10.1002/pds.3291

  14. Design of a score to identify hospitalized patients at risk of drug-related problems

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 9, September 2014, Pages: 923–932, Olatz Urbina, Olivia Ferrández, Santiago Grau, Sonia Luque, Sergi Mojal, Monica Marin-Casino, Javier Mateu-de-Antonio, Alexia Carmona, David Conde-Estévez, Merce Espona, Elena González, Marta Riu and Esther Salas

    Article first published online : 10 MAY 2014, DOI: 10.1002/pds.3634

  15. You have free access to this content
    A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S1, January 2012, Pages: 100–128, Susan E. Andrade, Leslie R. Harrold, Jennifer Tjia, Sarah L. Cutrona, Jane S. Saczynski, Katherine S. Dodd, Robert J. Goldberg and Jerry H. Gurwitz

    Article first published online : 19 JAN 2012, DOI: 10.1002/pds.2312

  16. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 623–631, Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin

    Article first published online : 17 APR 2013, DOI: 10.1002/pds.3432

  17. Application of marginal structural models in pharmacoepidemiologic studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 560–571, Shibing Yang, Charles B. Eaton, Juan Lu and Kate L. Lapane

    Article first published online : 24 JAN 2014, DOI: 10.1002/pds.3569

  18. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 11, November 2012, Pages: 1155–1172, Charles E. Leonard, Cristin P. Freeman, Craig W. Newcomb, Peter P. Reese, Maximilian Herlim, Warren B. Bilker, Sean Hennessy and Brian L. Strom

    Article first published online : 9 AUG 2012, DOI: 10.1002/pds.3329

  19. Influence on quality of life from an early cinacalcet prescription for secondary hyperparathyroidism in dialysis

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 2, February 2015, Pages: 187–196, Pierre Filipozzi, Carole Ayav, Marie-Line Erpelding, Michèle Kessler, Laurent Brunaud and Luc Frimat

    Article first published online : 11 AUG 2014, DOI: 10.1002/pds.3683

  20. You have free access to this content
    General population's knowledge and attitudes about antibiotics: a systematic review and meta-analysis

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 1, January 2015, Pages: 2–10, Maria R. Gualano, Renata Gili, Giacomo Scaioli, Fabrizio Bert and Roberta Siliquini

    Article first published online : 24 SEP 2014, DOI: 10.1002/pds.3716